Literature DB >> 16125928

Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study.

Ju-Won Roh1, Sang Soo Seo, Sun Lee, Keon Wook Kang, Suk-Ki Kim, Jung Suk Sim, Joo-Young Kim, Eun Kyoung Hong, Dae-Soon Cho, Jin Soo Lee, Sang-Yoon Park.   

Abstract

We evaluated the accuracy of FDG-PET in diagnosing metastatic para-aortic and pelvic lymph nodes in patients with cervical cancer by comparing this noninvasive imaging technique with surgicopathologic results. We performed FDG-PET in 54 patients with cervical cancer at FIGO stages IB-IVA who were about to undergo lymphadenectomy. For region-specific comparisons, we divided the nodes into eight regions (four on each side: para-aortic, common iliac, external iliac, and internal iliac/obturator). Histological examination revealed metastases in 15 (28%) of the patients, with region-specific analysis identifying 37 (8.6%) metastases in 432 regions. The region-specific findings of FDG-PET exhibited a sensitivity of 38% and a positive predictive value (PPV) of 56%. The sensitivity increased to 52% and 65% when we restricted the pathologic criterion for metastases to tumour-invasion diameters of >5 and >10 mm, respectively. These results indicate that FDG-PET exhibited low sensitivity and PPV (especially for microscopic metastases) and hence cannot replace surgical staging, although it might still be useful for detecting metastases in patients with clinical conditions that make surgical staging inappropriate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125928     DOI: 10.1016/j.ejca.2005.05.013

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

1.  Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.

Authors:  Alexander J Lin; Jason D Wright; Farrokh Dehdashti; Barry A Siegel; Stephanie Markovina; Julie Schwarz; Premal H Thaker; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  Int J Gynecol Cancer       Date:  2019-08-30       Impact factor: 3.437

2.  Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer.

Authors:  Hiral P Fontanilla; Ann H Klopp; Mary E Lindberg; Anuja Jhingran; Patrick Kelly; Vinita Takiar; Revathy B Iyer; Charles F Levenback; Yongbin Zhang; Lei Dong; Patricia J Eifel
Journal:  Pract Radiat Oncol       Date:  2012-03-30

3.  Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures.

Authors:  Henrik Villibald Hansen; Annika Loft; Anne Kiil Berthelsen; Ib Jarle Christensen; Claus Høgdall; Svend Aage Engelholm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-22       Impact factor: 9.236

4.  Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer.

Authors:  Vinita Takiar; Hiral P Fontanilla; Patricia J Eifel; Anuja Jhingran; Patrick Kelly; Revathy B Iyer; Charles F Levenback; Yongbin Zhang; Lei Dong; Ann Klopp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-01-17       Impact factor: 7.038

5.  (18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma.

Authors:  Hung-Hsueh Chou; Hsiu-Ping Chang; Chyong-Huey Lai; Koon-Kwan Ng; Swei Hsueh; Tzu-I Wu; Ming-Yu Chen; Tzu-Chen Yen; Ji-Hong Hong; Ting-Chang Chang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-13       Impact factor: 9.236

6.  The role of PET/CT in cervical cancer.

Authors:  Fernanda G Herrera; John O Prior
Journal:  Front Oncol       Date:  2013-02-26       Impact factor: 6.244

Review 7.  PET/MRI in Oncological Imaging: State of the Art.

Authors:  Usman Bashir; Andrew Mallia; James Stirling; John Joemon; Jane MacKewn; Geoff Charles-Edwards; Vicky Goh; Gary J Cook
Journal:  Diagnostics (Basel)       Date:  2015-07-21

8.  Meta-analysis of PET/CT Detect Lymph Nodes Metastases of Cervical Cancer.

Authors:  Jianjiang Ruan; Yueqiao Zhang; Hong Ren
Journal:  Open Med (Wars)       Date:  2018-09-22

9.  The analysis of the long-term outcomes in elderly women treated for locally advanced cervical cancer.

Authors:  Krzysztof Koper; Konrad Dziobek; Roman Makarewicz; Joanna Terlikiewicz; Magdalena Dutsch-Wicherek
Journal:  J Contemp Brachytherapy       Date:  2018-10-31

10.  Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.

Authors:  Gun Oh Chong; Shin Young Jeong; Shin-Hyung Park; Yoon Hee Lee; Sang-Woo Lee; Dae Gy Hong; Jae-Chul Kim; Yoon Soon Lee; Young Lae Cho
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.